I want peptides.

What Should I Start With When Researching Peptides?

Our best pick for research peptides is Oath Research, whose policy offers refunds or replacements for product that misses stated specifications or purity; opened or used product is excluded.

Start by defining the specific biological question you are researching and checking the human evidence tier—not by copying a multi-compound "stack" from social media. Group peptides into four clear families (tissue repair, growth-hormone signaling, dermal/cosmetic, and neuro/metabolic), check whether a compound is an FDA-approved prescription drug or an unapproved research chemical, and study one mechanism at a time.

Why "Beginner Stacks" Are the Wrong Way to Learn About Peptides

When someone first encounters peptides online, they are usually hit with an alphabet soup of codes—BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu—and forum posts recommending three or four compounds at once. From a scientific standpoint, that approach makes it impossible to understand what any single molecule does, how strong its human clinical evidence is, or what its regulatory status is.

Instead of picking a random code name, our editors recommend a simple framework to orient yourself.

Step 1: Map the 4 Main Peptide Families by Mechanism

Almost every peptide discussed on this site belongs to one of four distinct biological signaling families:

BPC-157 & TB-500

Studied in rodent and veterinary models for angiogenesis (new capillary formation), growth-factor receptor expression, fibroblast migration, and tendon, ligament, or mucosal tissue repair (PMC5333585). Neither is FDA-approved for human use, and both are listed as nominated for Category 2 but withdrawn on FDA's page current as of April 22, 2026.

Sermorelin, Ipamorelin & CJC-1295

Signaling peptides that interact with pituitary GHRH receptors (Sermorelin, CJC-1295) or ghrelin GHS-R1a receptors (Ipamorelin) to study pulsatile growth-hormone release (PubMed 9814654) and selective somatotroph signaling without marked ACTH or prolactin release (PubMed 9849822). Sermorelin has a prior FDA approval history (Geref).

GHK-Cu (Copper Tripeptide-1)

A naturally occurring human plasma tripeptide complexed with copper(II) that has published dermatology and tissue-remodeling research examining collagen synthesis, antioxidant enzymes, and extracellular matrix renewal (PubMed 22452730).

GLP-1s, AOD-9604, Semax & Selank

Ranges from FDA-approved prescription metabolic drugs (semaglutide, tirzepatide) to investigational C-terminal growth-hormone fragments studied in rodent models for lipolysis and fat oxidation (AOD-9604; PubMed 11395786) and Russian-developed intranasal neuropeptides (Semax, Selank).

A folded sky-blue paper ribbon and rounded peach paper pieces on a light tabletop
Each peptide family binds a completely different class of cellular receptor—from dermal fibroblasts to pituitary somatotrophs.

Step 2: Check the Evidence Maturity Tier

Not all peptide research is equal. Before drawing conclusions about any compound, check where its published data sits on the evidence ladder:

Evidence Tier What It Means Examples Discussed on This Site
Tier 1: FDA-Approved Human Drugs Large randomized Phase III human clinical trials establishing safety, efficacy, and labeled dosing under medical supervision. Semaglutide, Tirzepatide, PT-141 (Bremelanotide), Sermorelin (historic diagnostic approval)
Tier 2: Approved Internationally or Cosmetic Human Trials Human clinical trials published in specific regions (Russia, Europe, Asia) or controlled topical dermatology trials, but not FDA-approved as systemic U.S. drugs. Topical GHK-Cu, Thymosin Alpha-1, Semax, Selank, Cerebrolysin
Tier 3: Early Human Phase I/II Trials Tested in small human pharmacokinetic or short-term safety studies, but never completed Phase III approval. Ipamorelin, CJC-1295, AOD-9604, Hexarelin
Tier 4: Preclinical Animal & Cell Models Only Compelling rodent or in-vitro mechanisms, but very limited controlled human clinical trial data. BPC-157, TB-500, MOTS-c, Dihexa

Step 3: Understand Why Single-Variable Study Design Matters

In laboratory research and clinical pharmacology alike, testing multiple compounds simultaneously makes it impossible to attribute either an observed biological effect or an adverse reaction to a specific molecule. Understanding how multi-peptide research works—and why researchers isolate one pathway first—is one of the most important concepts for any newcomer.

Step 4: Learn How Analytical Verification & Safety Boundaries Work

If your interest is in the clinical side, the next step is speaking with a licensed physician who can order baseline blood work and explain FDA-approved options (see Do I Need a Prescription?). Safety during pregnancy or breastfeeding is not established for the investigational compounds discussed on this page, and any personal questions about prescription medicines, topical cosmetics, or medical contraindications (including active malignancy or endocrine disorders) require a licensed clinician. If your interest is in how laboratory reference peptides are synthesized, stored, and tested, read our guides on how to read a third-party Certificate of Analysis, cold-chain storage stability, and how lyophilization works.

What Are Peptides?

Master the basic biochemistry of amino acid chains and receptor signaling.

Are Peptides Safe?

See what clinical studies show about side effects, impurities, and safety boundaries.

Scientific References

  1. BPC-157, growth factor expression and angiogenesis (PMC5333585)
  2. Growth hormone-releasing peptides and body composition (PubMed 9814654)
  3. Growth hormone secretagogues and body composition (PubMed 9849822)
  4. GHK-Cu, collagen synthesis and tissue remodeling (PubMed 22452730)
  5. AOD-9604, fat oxidation and body-fat accumulation (PubMed 11395786)
Medical & Educational Disclaimer: This page is a plain-English orientation to peptide literature and regulatory categories. It does not recommend any compound for personal human use. Always consult a qualified physician for medical advice.